US EditionBlood test for ovarian cancer misses some Black and Native American patients, study finds
- A new study finds that a common blood test may miss ovarian cancer in some Black and Native American patients, delaying treatment.
- Researchers reported that Black and Native American patients were 23% less likely to have elevated levels at diagnosis compared to white patients.
- Dr. Anna Jo Smith noted that new thresholds for the blood test could lead to better care and reduced disparities in treatment.
- The findings highlight the necessity of adjusting test thresholds to improve early detection and care for all racial and ethnic groups.
83 Articles
83 Articles
MHA Nation raises $75,000 during Ice Warrior Plunge
MANDAN, ND (KXNET) — The Mandan, Hidatsa, and Arikara (MHA) Nation recently held its 9th annual MHA Ice Warrior Plunge to raise money for cancer services for Native people. The event took place on February 26, and they raised $75,000. A portion of the money will be donated to the American Indian Cancer Foundation, which helps provide access to prevention, early detection, treatment, and survivor support for American Indian and Alaska Native peop…
Los Angeles Times
Independent EspañolBlood test does not detect ovarian cancer in some patients, according to study
A common blood test may not detect ovarian cancer in some Black and Native American patients, delaying treatment, according to a new study in the United States.
Tioga Publishing
Ovarian Cancer Test May Miss Black and Native American Patients
Key Takeaways
MedPage Today
Anti-Aging, Acupuncture and Health NewsOvarian Cancer Blood Test Misses Some Black, Native American Patients
(MedPage Today) -- The cancer antigen (CA)-125 test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study found. It's the latest example of medical tests that contribute to healthcare disparities...
Ovarian cancer blood test misses some Black and Native American patients, study finds
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying their treatment. It’s the latest example of medical tests contributing to health care disparities.
Coverage Details
Bias Distribution
- 42% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
